Literature DB >> 25600557

Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012.

P Huang1, L G Zhu2, X J Zhai2, Y F Zhu2, M Yue3, J Su1, J Wang4, H T Yang2, Y Zhang5, H B Shen1, Z H Peng1, R B Yu1.   

Abstract

Limited information is available on the prevalence of hepatitis C virus (HCV) in the general population in China. A community-based epidemiological study was conducted in three counties in eastern China. A total of 149 175 individuals were investigated in 60 communities in three counties in Jiangsu province, eastern China, of whom 1175 subjects [0·79%, 95% confidence interval (CI) 0·74-0·83] were HCV antibody positive. The prevalence was low in children (0·09%, 95% CI 0·04-0·17), but increased progressively from adolescents (0·20%, 95% CI 0·15-0·28) to adults aged ⩾21 years (95% CI 0·15-1·64). Women had a higher prevalence of HCV infection than men in most age groups. In a multilevel regression analysis, age, sex, education, occupation, blood transfusion [odds ratio (OR) 2·91, 95% CI 1·09-5·37], invasive testing (OR 1·28, 95% CI 1·14-1·61), and dental therapy (OR 2·27, 95% CI 1·41-3·42) were associated with HCV infection. In conclusion, although the prevalence of HCV in this population was lower than reported from national levels, the total reservoir of infection is significant and warrants public health measures, such as health education to limit the magnitude of the problem.

Entities:  

Keywords:  Epidemiological study; general population; hepatitis C virus antibody; risk factor

Mesh:

Year:  2015        PMID: 25600557      PMCID: PMC9151013          DOI: 10.1017/S0950268814003719

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  26 in total

Review 1.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Authors:  J M Micallef; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

Review 2.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

3.  Institute of Medicine recommendations for the prevention and control of hepatitis B and C.

Authors:  Abigail E Mitchell; Heather M Colvin; R Palmer Beasley
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

4.  Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection.

Authors:  Andrew J Muir; Mitchell L Shiffman; Atif Zaman; Boris Yoffe; Andrew de la Torre; Steven Flamm; Stuart C Gordon; Paul Marotta; John M Vierling; Juan Carlos Lopez-Talavera; Kelly Byrnes-Blake; David Fontana; Jeremy Freeman; Todd Gray; Diana Hausman; Naomi N Hunder; Eric Lawitz
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Outcome of hepatitis C virus infection in Chinese paid plasma donors: a 12-19-year cohort study.

Authors:  Hui-Ying Rao; De-Gui Sun; Rui-Feng Yang; Feng Liu; Jian Wang; Bo Feng; Nan Wu; Ji-Lian Fang; Guang-Jun Song; Hui Ma; Fang Guo; Jiang-Hua Wang; Xiao-Bo Li; Qian Jin; Hong Qin; Hui Zhuang; Lai Wei
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

6.  Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China.

Authors:  Yuhua Ruan; Shu Liang; Junling Zhu; Xudong Li; Stephen W Pan; Qianping Liu; Benli Song; Qixing Wang; Hui Xing; Yiming Shao
Journal:  Sex Transm Dis       Date:  2013-04       Impact factor: 2.830

7.  Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.

Authors:  A Charlebois; L Lee; E Cooper; K Mason; J Powis
Journal:  J Viral Hepat       Date:  2012-07-31       Impact factor: 3.728

8.  Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region.

Authors:  Yan-Heng Zhou; Feng-Liang Liu; Zhi-Hong Yao; Lin Duo; Hong Li; Yi Sun; Yong-Tang Zheng
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

9.  General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007.

Authors:  Jian Lu; Yongdong Zhou; Xiaojing Lin; Yongzhen Jiang; Ruiguang Tian; Yonghui Zhang; Jia Wu; Fengwei Zhang; Yong Zhang; Yue Wang; Shengli Bi
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

10.  Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.

Authors:  Jannie van der Helm; Ronald Geskus; Caroline Sabin; Laurence Meyer; Julia Del Amo; Geneviève Chêne; Maria Dorrucci; Roberto Muga; Kholoud Porter; Maria Prins
Journal:  Gastroenterology       Date:  2012-12-22       Impact factor: 22.682

View more
  3 in total

Review 1.  Prevalence of Anti-HCV Antibody Among the General Population in Mainland China Between 1991 and 2015: A Systematic Review and Meta-analysis.

Authors:  Yuhua Gao; Jun Yang; Feng Sun; Siyan Zhan; Zhongliao Fang; Xueen Liu; Hui Zhuang
Journal:  Open Forum Infect Dis       Date:  2019-02-06       Impact factor: 3.835

2.  Synergistic effects of organic fertilizer and corn straw on microorganisms of pepper continuous cropping soil in China.

Authors:  Jingxia Gao; Hongxia Pei; Hua Xie
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

3.  Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.

Authors:  Ji Xiong; Jun Wang; Juan Huang; Wenjing Sun; Jun Wang; Dongfeng Chen
Journal:  Clinics (Sao Paulo)       Date:  2015-08       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.